OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OcuNexus Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10810
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OcuNexus Therapeutics Inc (OcuNexus Therapeutics) is a development stage biopharmaceutical company engaged in novel therapeutics for unmet clinical needs in ophthalmology. It has highly differentiated, lead drug candidates based upon a novel mechanism of action such as Gap Junction Channel Modulation. The company’s product pipeline comprises of proprietary connexin hemichannel modulators such as Nexagon, Peptagon and HCB1019 with distinct modes of action in topical, systemic, intravitreal and oral administration. Its fundamental modulation technology has been shown work in a variety of tissue types including, eye, skin, brain, nerve, and spinal cord. OcuNexus is headquartered in San Diego, California, the US.

OcuNexus Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OcuNexus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CoDa Therapeutics Raises USD0.8 Million Financing 11
CoDa Therapeutics Raises USD1.2 Million in Venture Financing 12
CoDa Therapeutics Raises USD1 Million in Venture Financing 13
CoDa Therapeutics Raises USD2.5 Million in Venture Financing 14
CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 15
Licensing Agreements 17
Eyevance Pharma Enters into Licensing Agreement with OcuNexus Therapeutics 17
OcuNexus Therapeutics Inc – Key Competitors 18
OcuNexus Therapeutics Inc – Key Employees 19
OcuNexus Therapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jan 02, 2018: Ocunexus Therapeutics appoints Dr. Brian Levy as CEO 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OcuNexus Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OcuNexus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CoDa Therapeutics Raises USD0.8 Million Financing 11
CoDa Therapeutics Raises USD1.2 Million in Venture Financing 12
CoDa Therapeutics Raises USD1 Million in Venture Financing 13
CoDa Therapeutics Raises USD2.5 Million in Venture Financing 14
CoDa Therapeutics Raises Additional US$20 Million In Series B Financing 15
Eyevance Pharma Enters into Licensing Agreement with OcuNexus Therapeutics 17
OcuNexus Therapeutics Inc, Key Competitors 18
OcuNexus Therapeutics Inc, Key Employees 19

List of Figures
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OcuNexus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OcuNexus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Billabong International Limited (BBG):企業の財務・戦略的SWOT分析
    Billabong International Limited (BBG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ulta Salon, Cosmetics & Fragrance Inc:戦略・SWOT・企業財務分析
    Ulta Salon, Cosmetics & Fragrance Inc - Strategy, SWOT and Corporate Finance Report Summary Ulta Salon, Cosmetics & Fragrance Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Gas Plus s.p.a.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gas Plus s.p.a. Mergers and Acq …
  • Pharmena SA (PHR):企業の財務及び戦略的SWOT分析
    Summary Pharmena SA (Pharmena) is a pharmaceutical company that develops and commercializes pharmaceutical drugs for dermatological and other therapeutic applications. The company offers products to prevent dandruff, hair loss and stimulate hair growth. It also offers products to treat acne and prev …
  • Buccaneer Energy Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Buccaneer Energy Limited Merger …
  • KenolKobil Limited (KOCL):企業の財務及び戦略的SWOT分析
    Summary KenolKobil Limited (KenolKobil) is an oil marketing company that operates, markets and sells petroleum products. The company offers petroleum products such as aviation fuels, motor fuels, and liquefied petroleum gas, lubricants, industrial oils and other specialist oils, among others. KenolK …
  • Seair, Inc. (SDS):企業のM&A・提携動向(石油・ガス分野)
    Summary Seair, Inc. (Seair) is a clean technology company that carries out research and development, production and sale of diffusion and sterilization technologies. It focuses on commercializing advanced waste water and industrial fluid treatment solutions. The company offers high performance propr …
  • Norse Energy Corporation ASA (formerly Northern Oil ASA):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Norse Energy Corporation ASA (f …
  • Cintas Corporation:企業の戦略・SWOT・財務情報
    Cintas Corporation - Strategy, SWOT and Corporate Finance Report Summary Cintas Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • IFFCO-Tokio General Insurance Co. Ltd.:企業の戦略・SWOT・財務分析
    SummaryIFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of t …
  • Seadrill Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Seadrill Limited Mergers and Ac …
  • Oracle Energy Corporation (OEC):企業の財務及び戦略的SWOT分析
    Summary Oracle Energy Corporation (Oracle Energy) is an oil and gas company that acquires, explores and evaluates oil and gas properties. The company also offers critical assessment and mitigation of risk in oil and gas exploration. It operates projects in Portugal's southern Lusitanian Basin and in …
  • DCO Energy LLC-エネルギー分野:企業M&A・提携分析
    Summary DCO Energy LLC (DCO) is an energy development company that constructs, operates, develops, and maintains cogeneration and renewable energy projects across the US. The company's services include financing, performance testing, equipment and systems analyses, retro-commissioning services, ener …
  • BioVectra Inc.(製薬・医療分野):企業M&A動向
    Summary BioVectra Inc. (BioVectra) is a pharmaceutical company. It undertakes the development, manufacturing and supply of active pharmaceutical ingredients, chemical intermediates and bioprocessing reagents. The company’s product portfolio includes reducing reagents, bioprocessing reagents, enzymes …
  • Swissport International Ltd.:企業の戦略・SWOT・財務情報
    Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Birchall Foodservice:企業概要およびSWOT分析
    Summary Canadean's "Birchall Foodservice: Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company histor …
  • Sayaji Hotels Limited:企業の戦略・SWOT・財務分析
    SummarySayaji Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • The Chugoku Bank, Limited:企業の戦略・SWOT・財務分析
    SummaryThe Chugoku Bank, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Labatt Food Service :企業の戦略・SWOT・財務分析
    SummaryLabatt Food Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Lundin Mining Corporation:企業の戦略・SWOT・財務分析
    SummaryLundin Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆